Enhanced Delivery of Rituximab Into Brain and Lymph Nodes Using Timed-Release Nanocapsules in Non-Human Primates is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0.494. It has been cited 26 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.494
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R01CA232015-05
Nanodelivery platform for antibody drugs targeting NHL
National Institutes of Health
Grant: 1R21AI114433-01
Gene engineering using CRISPR/Cas9 mutagenesis to eliminate latent HIV-1
National Institutes of Health
Grant: 5R01AI110297-02
Hematopoietic stem/progenitor cell reservoirs
National Institutes of Health
Grant: 5R01AI110200-02
Gene-engineered stem cell memory T-cells with anti-HIV chimeric antigen receptors
National Institutes of Health
Grant: 7R01CA232015-03
Nanodelivery platform for antibody drugs targeting NHL
National Institutes of Health
Grant: 5R01HL125030-02
Survival of the fittest HSPC repopulating clones by anti-HIV-1 gene-modification
Fields of Study
Keywords
Sustainable Development Goals